Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak
Publication date: Available online 31 July 2020Source: Revista Española de Cardiología (English Edition)Author(s): Jorge Solano-López, José Luis Zamorano, Ana Pardo Sanz, Ignacio Amat-Santos, Fernando Sarnago, Enrique Gutiérrez Ibañes, Juan Sanchis, Juan Ramón Rey Blas, Joan Antoni Gómez-Hospital, Sandra Santos Martínez, Nicolás Manuel Maneiro-Melón, Roberto Mateos Gaitán, Jessika González D’gregorio, Luisa Salido, José L. Mestre, Marcelo Sanmartín, Ángel Sánchez-Recalde
Conclusion During the early phase, the COVID-19 outbreak was associated with a lower rate of admissions for ACS, with a substantial impact on the time delay presentation of STEMI patients, but apparently without affecting the in-hospital outcomes.
Aims The aim of this study was to report the prevalence, clinical features and outcomes of patients with ST-elevation myocardial infarction (STEMI) hospitalized during the Corona-Virus Disease 2019 (COVID-19) outbreak compared with those admitted in a previous equivalent period. Methods and results Eighty-five patients admitted for STEMI at a high-volume Italian centre were included. Patients hospitalized during the COVID-19 outbreak (21 February–10 April 2020) (40%) were compared with those admitted in pre-COVID-19 period (3 January–20 February 2020) (60%). A 43% reduction in STEMI admissions was observed...
Cardiologists are finding that problems aren ’t related to age or severity of infectionCoronavirus – latest updatesSee all our coronavirus coverageOn 29 February, Melissa Vanier, a 52-year-old postal worker from Vancouver, had just returned from holiday in Cuba when she fell seriously ill with Covid-19. “For the entire month of March I felt like I had broken glass in my throat,” she says, describing a range of symptoms that included fever, migraines, extreme fatigue, memory loss and brain fog. “I had to sleep on my stomach because otherwise it felt like someone was strangling me.”By the ...
CONCLUSIONS: Implementation of the dedicated COVID-19 primary PCI protocol for patients with STEMI allowed to achieve similar target times for reperfusion and short-term clinical outcome in comparison to pre-pandemic era and staff safety. PMID: 32955819 [PubMed - as supplied by publisher]
To explore the effect of COVID-19 outbreak on the treatment time of patients with ST-segment elevation myocardial infarction (STEMI) in Hangzhou, China.
zquez-González N, Vázquez-Rodríguez JM PMID: 32748944 [PubMed - as supplied by publisher]
ConclusionsThe COVID-19 pandemic was associated with a significant decrease in all-cause admission and admissions due to cardiovascular events in the emergency department. Regarding acute cerebrovascular events there was a numerical decrease but no significant difference.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for the coronavirus disease 2019 (COVID-19), overwhelmed worldwide healthcare systems requiring abrupt changes in hospitals reorganization and human resources allocation. Recent literature data demonstrated a global reduction of hospitalizations for acute myocardial infarction  and urgent pacemaker implantations , mainly related to the fear of COVID-19 infection, with consequent development of life-threating complications due to delayed treatment.
ConclusionsClinically important indicators for STEMI management were unaffected at the peak of COVID-19, suggesting that the pre-existing logistic structure in the regional STEMI networks preserved high-quality standards even when challenged by a threatening pandemic.Clinical trial registrationNCT00794001
Edinburgh University team find heart damage in 55% of ultrasounds from 69 countriesCoronavirus – latest updatesSee all our coronavirus coverageHeart scans of coronavirus patients in hospital have revealed a range of abnormalities that can disrupt the ability to pump blood and in severe cases lead to a life-threatening failure in the organ.Doctors at Edinburgh University examined ultrasound scans known as echocardiograms from more than 1,200 patients in 69 countries and found heart problems in 55%, with one in seven exhibiting signs of “severe abnormalities”.Continue reading...